November 2011

Cancer treatment addresses a patient's physical health but the mental state of the patient is something that might need more than an oncologist's expertise.

Antiresorptive medicines used to reduce the loss of bone mass related to bone metastases or treatment toxicity are associated with an increased risk of ONJ.

Awareness and treatment of oncofertility have been given a tremendous boost over the past 5 years by the Oncofertility Consortium.

Beth Baughman DuPree, MD, FACS, discussed the latest in breast cancer care at the 3rd Annual NCONN Conference.

At NCONN 2011, Sean Grimm, MD, discussed the management of Glioblastoma multiforme, the most common malignant primary brain tumor.

The National Coalition of Oncology Nurse Navigators (NCONN) held its 3rd Annual Conference, Changing the Face of Cancer Care, from September 8-10 in San Diego, California.

Lynch Syndrome International (LSI) fills a tremendous void in the arena of hereditary cancers by providing networking, organization, and a voice.

Because of bendamustine's potential to cause pain and erythema to the extent that hospitalization has been required for some patients, it would be prudent to administer bendamustine using vesicant precautions.

Young adults facing a cancer diagnosis have unique needs and barriers to care and survivorship that can present a difficult challenge to ONNs.

Navigation programs in healthcare facilities are proliferating. However, there is considerable variability in their scope and implementation.